Vitamin E suppliers continue to try to raise prices, with some success. Prices appear to be increasing, but at the same time new demand is sluggish as long-term contracts are already in place. The same is true for Vitamin D3 500. Read more in this week’s Feed Additives Snapshot (Week 26).
Vitamin A 1000 is stable for now, with very few transactions. Vitamin B1 is trending steadily. The rise in container freight rates is also starting to affect relatively cheap vitamins such as Chinese-made choline chloride, which is trending steadily.
Partnership with Feed Additive Prices
Vitamin E 50%
Suppliers continue to offer higher prices to boost market prices. In some cases, prices are rising, but there are no significant changes so far. Many buyers have signed futures contracts for Vitamin E recently or have already been doing so for some time. Summer plant maintenance for some suppliers will start soon or has already started. Higher container shipping costs will also add to the final Vitamin E price. However, the market is relatively quiet and in actual transactions, prices are stable or somewhat firm. Most of the third quarter is contracted, as well as some of the fourth quarter.
Vitamin A 1000
Despite several attempts to drive up prices, the market has remained relatively stable and calm in recent weeks. Some market participants point to low inventories, material delays and container shipping weighing on prices. But so far, prices have remained stable and buyers have shown little reaction to these arguments and facts. A significant portion of the third quarter is already under contract.
Vitamin D3 500
Suppliers are very motivated to raise prices after a long period of relatively sluggish market prices. New price offers are certainly higher compared to a few weeks ago. However, actual market transactions are few and do not reflect the actual robust market so far. Many buyers already have pending contracts through Q4 at old price levels and have not entered the market for more material. Container freight rate increases have had some impact but are not significant. The market is quiet despite delays from China, rising container freight rates and rising FOB prices from China. A significant portion of Q3 is already contracted, with some overlapping into Q4 as well.
Vitamin B2 80%
Recently, the European market has been a bit firmer due to supply shortages from local EU suppliers. However, compared to a few weeks ago, the situation seems to have stabilized at a slightly higher price level. In other regions, prices have remained more or less stable, despite continued requests from manufacturers to increase prices. However, demand has not been sufficiently supportive. A large part of the third quarter has already been contracted, mainly for strategic reasons.
D-Carpan
Despite the rising container costs, the final prices of d-Carpan in each region have not really changed. The market has stabilized at low levels in most regions at the moment as supplies are generally adequate and suppliers are keen to maintain market share and move inventory. For strategic reasons, there is already ample headroom for the third quarter.
Vitamin B3
The market is stable, with no significant changes observed or expected compared to the previous week. In this case, the increase in container shipping costs will not have a significant impact on the final product price. Demand is said to remain sluggish, so a significant price increase is unlikely in the short term. The period when prices were lower compared to today will be covered until the third quarter, and possibly even longer.
Biotin
At this time, we are not seeing any change in the biotin market. Supply is ample and long-term contracts have been signed or are pending. Prices remain historically low. A significant portion of Q3 is under contract and, in some cases, buyers have signed long-term agreements through late 2024.
Vitamin C 35% Mono
Suppliers are attempting to raise prices through production cuts, extended maintenance periods, and recently announced price increases. Until recently, the Vitamin C market has been somewhat bearish, and it remains to be seen whether this new bullish attitude from suppliers will have any impact on the market. However, prices are still higher than they were a year ago. Q3 and part of Q4 are primarily contracted under older contracts at lower prices.
